Widely used arthritis pill protects against skin cancer, study suggests

Published December 7, 2010

Widely used arthritis pill protects against skin cancer, study suggests
A widely used arthritis drug reduces the incidence of non-melanoma skin cancers — the most common cancers in humans — according to a new study. The COX-2 inhibitor celecoxib (Celebrex), which is approved for the treatment of arthritis and acute pain, led to a 62 percent reduction in non-melanoma skin cancers. In the future, a combination of medications that include sunscreens and COX …
Read more on Science Daily

China Pharma Holdings, Inc. Announces Successful Completion of Clinical Trials of the Cholesterol-Lowering Drug …
China Pharma Holdings, Inc. , which develops, manufactures, and markets specialty pharmaceutical products in China, today announced the completion of clinical trials of the cholesterol-lowering drug, rosuvastatin , which the Company intends to commercialize in the large and expanding Chinese healthcare market. Â
Read more on PR Newswire via Yahoo! Finance

Panel Recommends Expanding Use Of Stomach Bands
About 12 million more obese Americans could soon qualify for surgery to implant a small, flexible stomach band designed to help them lose weight by dramatically limiting their food intake. The Food and Drug Administration will make a final decision on the Lap-Band in the coming months.
Read more on CBS 13 Sacramento